tiprankstipranks
Ascentage Pharma Group International (HK:6855)
:6855
Hong Kong Market
6855
Ascentage Pharma Group International
RESEARCH TOOLSreports
Want to see HK:6855 full AI Analyst Report?

Ascentage Pharma Group International (6855) Income Statement

4 Followers

Ascentage Pharma Group International Income Statement

Last quarter (Q4 2025), Ascentage Pharma Group International's total revenue was ¥334.74M, an increase of 322.21% from the same quarter last year. In Q4, Ascentage Pharma Group International's net income was ¥-641.12M. See Ascentage Pharma Group International’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 559.26M¥ 980.65M¥ 221.98M¥ 209.71M¥ 27.91M
Gross Profit
¥ 427.35M¥ 951.57M¥ 191.44M¥ 187.71M¥ 24.58M
Operating Expenses
¥ 1.61B¥ 1.33B¥ 1.08B¥ 1.07B¥ 957.75M
Depreciation and Amortization
¥ 84.24M¥ 79.17M¥ 93.19M¥ 47.42M¥ 17.18M
EBITDA
¥ -1.10B¥ -299.63M¥ -743.61M¥ -835.99M¥ -915.99M
Operating Income
¥ -1.18B¥ -378.80M¥ -891.99M¥ -883.41M¥ -933.17M
Other Income/Expenses
¥ -23.24M¥ -16.45M¥ -40.87M¥ -3.77M¥ 100.92M
Pretax Income
¥ -1.20B¥ -395.25M¥ -932.86M¥ -887.17M¥ -832.25M
Net Income
¥ -1.21B¥ -405.43M¥ -925.64M¥ -882.92M¥ -782.42M
Per Share Metrics
Basic EPS
¥ -3.40¥ -1.34¥ -3.28¥ -3.35¥ -3.07
Diluted EPS
¥ -3.40¥ -1.34¥ -3.28¥ -3.35¥ -3.07
Weighted Average Shares Outstanding
 356.13M 302.06M 282.30M 263.67M 254.62M
Weighted Average Shares Outstanding (Diluted)
 356.13M 302.06M 282.30M 263.67M 254.62M
Currency in CNY

Ascentage Pharma Group International Earnings and Revenue History